Fahrner Jill A, Eguchi Sayaka, Herman James G, Baylin Stephen B
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland 21231-1000, USA.
Cancer Res. 2002 Dec 15;62(24):7213-8.
We examined the relationship between aberrant DNA hypermethylation and key histone code components at a hypermethylated, silenced tumor suppressor gene promoter in human cancer. In lower eukaryotes, methylated H3-lysine 9 (methyl-H3-K9) determines DNA methylation and correlates with repressed gene transcription. Here we show that a zone of deacetylated histone H3 plus methyl-H3-K9 surrounds a hypermethylated, silenced hMLH1 promoter, which, when unmethylated and active, is embedded in methyl-H3-K4 and acetylated H3. Inhibiting DNA methyltransferases, but not histone deacetylases, leads first to promoter demethylation, second to gene reexpression, and finally to complete histone code reversal. Our findings suggest a new paradigm-DNA methylation may directly, or indirectly by inhibiting transcription, maintain key repressive elements of the histone code at a hypermethylated gene promoter in cancer.
我们研究了人类癌症中一个高度甲基化且沉默的肿瘤抑制基因启动子处异常DNA高甲基化与关键组蛋白编码成分之间的关系。在低等真核生物中,甲基化的组蛋白H3赖氨酸9(甲基-H3-K9)决定DNA甲基化,并与基因转录抑制相关。在此我们表明,去乙酰化的组蛋白H3加上甲基-H3-K9区域环绕着一个高度甲基化且沉默的hMLH1启动子,而当该启动子未甲基化且具有活性时,它则处于甲基-H3-K4和乙酰化H3之中。抑制DNA甲基转移酶而非组蛋白去乙酰化酶,首先导致启动子去甲基化,其次导致基因重新表达,最终导致组蛋白编码完全逆转。我们的研究结果提示了一种新的模式——DNA甲基化可能直接地,或通过抑制转录间接地维持癌症中高度甲基化基因启动子处组蛋白编码的关键抑制元件。